Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 233-237

  Erichsen, Martina M ^a   Løvås, Kristian ^a,b   Fougner, Kristian J ^c   Svartberg, Johan ^d,e   Hauge, Erik R ^f   Bollerslev, Jens ^g,h   Berg, Jens P ^h,i,j   Mella, Bjarne ^k   Husebye, Eystein S ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f NKS Olaviken Hospital for Old Age Psychiatry   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^j AKER UNIVERSITY HOSPITAL   (Norway)

^k Østfold Hospital Trust   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RECEPTOR DAX 1;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; INFECTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NORWAY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SUDDEN DEATH; ADOLESCENT; AGED; CAUSE OF DEATH; CHILD; INCIDENCE; MIDDLE AGED; REGISTER; RISK FACTOR; STATISTICS;

ADDISON DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; FEMALE; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; NORWAY; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 61449102629     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0550     Document Type: Article

References (21)

1. Kong MF & Jeffcoate W. Eighty-six cases of Addison's disease. Clinical Endocrinology 1994 41 757-761.
2. Laureti S, Vecchi L, Santeusanio F & Falorni A. Is the prevalence of Addison's disease underestimated? Journal of Clinical Endocrinology and Metabolism 1999 84 1762.
3. Lovas K & Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology 2002 56 787-791.
4. Myhre AG, Undlien DE, Lovas K, Uhlving S, Nedrebo BG, Fougner KJ, Trovik T, Sorheim JI & Husebye ES. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. Journal of Clinical Endocrinology and Metabolism 2002 87 618-623.
5. Betterle C, Dal Pra C, Mantero F & Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-364.
6. Eisenbarth GS & Gottlieb PA. Autoimmune polyendocrine syndromes. New England Journal of Medicine 2004 350 2068-2079.
7. Nerup J. Addison's disease - clinical studies. A report of 108 cases. Acta Endocrinologica 1974 76 127-141.
8. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Journal of Clinical Endocrinology and Metabolism 2006 91 2843-2850.
9. Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM & Husebye ES. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. Journal of Clinical Endocrinology and Metabolism 2007 92 595-603.
10. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893.
11. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A & Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism 2006 91 4849-4853.
12. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431.
13. Filipsson H, Monson JP, Koltowska-Haggstrom M, Mattsson A & Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2006 91 3954-3961.
14. Løvås K & Husebye ES. High incidence and increasing prevalence of Addison's disease, an epidemiological study in western Norway. Clinical Endocrinology 2002 56 787-791.
15. al Sabri AM, Smith N & Busuttil A. Sudden death due to auto-immune Addison's disease in a 12-year-old girl. International Journal of Legal Medicine 1997 110 278-280.
16. Burke MP & Opeskin K. Adrenocortical insufficiency. American Journal of Forensic Medicine and Pathology 1999 20 60-65.
17. Keljo DJ & Squires RH Jr. Clinical problem-solving. Just in time. New England Journal of Medicine 1996 334 46-48.
18. Brosnan CM & Gowing NF. Addison's disease. BMJ 1996 312 1085-1087.
19. Mason AS, Meade TW, Lee JA & Morris JN. Epidemiological and clinical picture of Addison's disease. Lancet 1968 2 744-747.
20. Bensing S, Brandt L, Tabaroj F, Sjöberg O, Nilsson B, Ekbom A, Blomqvist P & Kämpe O. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clinical Endocrinology 2008 69 697-704.
21. The National Board of Health and Welfare Socialstyrelsen Dödsorsaker 2002. Causes of death 2002, p 21, Stocköholm: Sveriges officiella Statistik 2004.